Involvement of HSP70 in the protection of bicyclol on apoptosis of HepG2 cells intoxicated by d-galactosamine

Journal of Asian Natural Products Research

Volumn 12, Issue 4, 2010, Pages 313-323

  Bao, Xiu Qi ^a   Liu, Geng Tao ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Apoptosis; Bicyclol; Heat shock protein; Inducible nitric oxide synthase; Nuclear factor kappa B

Indexed keywords

ANTIVIRUS AGENT; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BICYCLOL; BIOLOGICAL MARKER; CASPASE 3; DNA; GALACTOSAMINE; HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL STRAIN HEPG2; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; LIVER PROTECTION; PROTEIN PHOSPHORYLATION;

APOPTOSIS; BIPHENYL COMPOUNDS; CASPASE 3; DOSE-RESPONSE RELATIONSHIP, DRUG; GALACTOSAMINE; HEP G2 CELLS; HEPATOCYTES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MOLECULAR STRUCTURE; NF-KAPPA B; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE TYPE II; STEREOISOMERISM;

EID: 77951687800     PISSN: 10286020     EISSN: 14772213     Source Type: Journal    
DOI: 10.1080/10286021003769924     Document Type: Article

References (22)

1. G.B. Yao, Y.Y. Ji, Q.H. Wang, X.Q. Zhou, D.Z. Xu, X.Y. Chen, and Q.B. Zhang, Chinese J. New Drugs Clin. Rem. 21, 457 (2002).
2. G.T. Liu, Med. Chem. 5, 29 (2009).
3. M. Li and G.T. Liu, Chinese Pharmacol. Bull. 22, 1438 (2006).
4. R. Arya, M. Mallik, and S.C. Lakhotia, J. Biosci. 32, 595 (2007).
5. T. Nishida, T. Matsura, J. Nakada, A. Togawa, M. Kai, I. Sumioka, Y. Minami, Y. Inagaki, Y. Ishibe, H. Ito, Y. Ohta, and K. Yamada, Toxicology 219, 187 (2006).
6. I. Sumioka, T. Matsura, M. Kai, and K. Yamada, Life Sci. 74, 2551 (2004).
7. X.Q. Bao and G.T. Liu, Cell Stress Chaperones 13, 355 (2008).
8. X.Q. Bao and G.T. Liu, Mol. Pharmacol. 75, 1180 (2009).
9. Y.M. Kim, M.E. de Vera, and S.C. Watkins, J. Biol. Chem. 272, 1402 (1997).
10. S. Ghosh, M.J. May, and E.B. Kopp, Annu. Rev. Immunol. 16, 225 (1998).
11. P. Bremner and M.J. Heinrich, Pharm. Pharmacol. 54, 453 (2002).
12. P.A. Baeuerle and T. Henkel, Annu. Rev. Immunol. 12, 141 (1994).
13. K.C. Huang, C.W. Chen, J.C. Chen, and W.W. Lin, J. Biomed. Sci. 10, 396 (2003).
14. S.C. Pingle, J.F. Sanchez, and D.M. Hallam, Mol. Pharmacol. 63, 1238 (2003).
15. S. Shishodia, S. Majumdar, S. Banerjee, and B.B. Aggarwal, Cancer Res. 63, 4375 (2003).
16. V.L. Gabai, A.B. Meriin, J.A. Yaglom, V.Z. Volloch, and M.Y. Sherman, FEBS Lett. 438, 1 (1998).
17. M.E. de Vera, Y.M. Kim, H.R. Wong, Q. Wang, T.R. Billiar, and D.A. Geller, Hepatology 24, 1238 (1996).
18. M.G. Clemens, Hepatology 30, 1 (1999).
19. Y.M. Kim, H.T. Chung, R.L. Simmons, and T.R. Billiar, J. Biol. Chem. 275, 10954 (2000).
20. E. Gumpricht, R. Dahl, B. Yerushalmi, M.W. Devereaux, and R.J. Sokol, J. Biol. Chem. 277, 25823 (2002).
21. A.M. Abou-Elella, E. Siendones, J. Padillo, J.L. Montero, M. De la Mata, and J.M. Relat, Can. J. Gastroenterol. 16, 791 (2002).
22. E. Siendones, D. Fouad, A.M. Abou-Elella, A. Quintero, P. Barrera, and J. Muntane, Nitric Oxide 8, 133 (2003).